MARCH 30, 2016
CTTI Project: Registry Trials
Meeting Objectives
- Identify essential elements of registries needed to successfully embed and conduct registry-based clinical trials
- Present findings from CTTI’s Registry Trials Project: Literature Review and Expert Interviews
- Receive feedback on potential benefits of and existing barriers to the use of registries in clinical trials
- Reach consensus on best practices to increase adoption of clinical trials within registries
Meeting Location:
DoubleTree Silver Spring Hotel by Hilton, 8727 Colesville Road, Silver Spring, MD 20910
Meeting Presentations:
- Introduction by Stephen Mikita, JD
- Introduction to CTTI by Sara Calvert
- Registry Trials Project Overview and Scope by Stephen Mikita, JD
- Regulatory Pathways: Devices vs. Drugs Are there roles for registries? by John Laschinger, MD
- CTTI Registry Trials Project: Literature Review by Sara Calvert
- Registry Trials Project Expert Interviews by Ted Lystig
- Registry-based RCTs: What we learned from the TASTE Trial by Ole Fröbert, MD, PhD, FESC
- Utility of Industry-Sponsored Oncology Registries For Clinical Trials – A Perspective by E. Dawn Flick, RPh MPH ScD
- Registry Trials VA Point of Care Trial and Precision Oncology Programs by Louis Fiore
- Registry Trials Breakout Sessions Report Outs
The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.